Longati P - Search Results

1

Cross-talk between the proto-oncogenes Met and Ron.

Follenzi A, Bakovic S, Gual P, Stella MC, Longati P, Comoglio PM. Follenzi A, et al. Among authors: longati p. Oncogene. 2000 Jun 22;19(27):3041-9. doi: 10.1038/sj.onc.1203620. Oncogene. 2000. PMID: 10871856

2

Functional regulation of semaphorin receptors by proprotein convertases.

Artigiani S, Barberis D, Fazzari P, Longati P, Angelini P, van de Loo JW, Comoglio PM, Tamagnone L. Artigiani S, et al. Among authors: longati p. J Biol Chem. 2003 Mar 21;278(12):10094-101. doi: 10.1074/jbc.M210156200. Epub 2003 Jan 17. J Biol Chem. 2003. PMID: 12533544 Free article.

3

Receptor tyrosine kinases as therapeutic targets: the model of the MET oncogene.

Longati P, Comoglio PM, Bardelli A. Longati P, et al. Curr Drug Targets. 2001 Mar;2(1):41-55. doi: 10.2174/1389450013348920. Curr Drug Targets. 2001. PMID: 11465538 Review.

4

MET(PRC) mutations in the Ron receptor result in upregulation of tyrosine kinase activity and acquisition of oncogenic potential.

Williams TA, Longati P, Pugliese L, Gual P, Bardelli A, Michieli P. Williams TA, et al. Among authors: longati p. J Cell Physiol. 1999 Dec;181(3):507-14. doi: 10.1002/(SICI)1097-4652(199912)181:3<507::AID-JCP15>3.0.CO;2-Q. J Cell Physiol. 1999. PMID: 10528237

5

A peptide representing the carboxyl-terminal tail of the met receptor inhibits kinase activity and invasive growth.

Bardelli A, Longati P, Williams TA, Benvenuti S, Comoglio PM. Bardelli A, et al. Among authors: longati p. J Biol Chem. 1999 Oct 8;274(41):29274-81. doi: 10.1074/jbc.274.41.29274. J Biol Chem. 1999. PMID: 10506185

6

Loss of the exon encoding the juxtamembrane domain is essential for the oncogenic activation of TPR-MET.

Vigna E, Gramaglia D, Longati P, Bardelli A, Comoglio PM. Vigna E, et al. Among authors: longati p. Oncogene. 1999 Jul 22;18(29):4275-81. doi: 10.1038/sj.onc.1202791. Oncogene. 1999. PMID: 10435641

7

Novel mutation in the ATP-binding site of the MET oncogene tyrosine kinase in a HPRCC family.

Olivero M, Valente G, Bardelli A, Longati P, Ferrero N, Cracco C, Terrone C, Rocca-Rossetti S, Comoglio PM, Di Renzo MF. Olivero M, et al. Among authors: longati p. Int J Cancer. 1999 Aug 27;82(5):640-3. doi: 10.1002/(sici)1097-0215(19990827)82:5<640::aid-ijc4>3.0.co;2-6. Int J Cancer. 1999. PMID: 10417759

8

Uncoupling signal transducers from oncogenic MET mutants abrogates cell transformation and inhibits invasive growth.

Bardelli A, Longati P, Gramaglia D, Basilico C, Tamagnone L, Giordano S, Ballinari D, Michieli P, Comoglio PM. Bardelli A, et al. Among authors: longati p. Proc Natl Acad Sci U S A. 1998 Nov 24;95(24):14379-83. doi: 10.1073/pnas.95.24.14379. Proc Natl Acad Sci U S A. 1998. PMID: 9826708 Free PMC article.

9

Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potential.

Bardelli A, Longati P, Gramaglia D, Stella MC, Comoglio PM. Bardelli A, et al. Among authors: longati p. Oncogene. 1997 Dec 18;15(25):3103-11. doi: 10.1038/sj.onc.1201561. Oncogene. 1997. PMID: 9444958

10

HGF receptor associates with the anti-apoptotic protein BAG-1 and prevents cell death.

Bardelli A, Longati P, Albero D, Goruppi S, Schneider C, Ponzetto C, Comoglio PM. Bardelli A, et al. Among authors: longati p. EMBO J. 1996 Nov 15;15(22):6205-12. EMBO J. 1996. PMID: 8947043 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results